Reisner, Y
Aversa, F
Martelli, M F
Article History
First Online: 3 June 2015
Competing interests
: YR has received consulting fees, owns equity in and has received grant support from Cell Source Ltd. FA has received consulting fees from Gilead, MSD, Pfizer, Genzyme, and received lecture fees from Gilead, MSD, Pfizer, and Celgene. MFM has declared no competing interests.